For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Doxylamine succinate/pyridoxine hydrochloride - Nausea and vomiting (pregnancy)
PAD Profile : Doxylamine succinate/pyridoxine hydrochloride - Nausea and vomiting (pregnancy)
Traffic Light Status
Status 1 of 1.
- Gastro-resistant tablets
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Domperidone
- Cyclizine hydrochloride
- Promethazine teoclate
- Promethazine hydrochloride
- Prochlorperazine maleate
- Chlorpromazine hydrochloride
- Metoclopramide hydrochloride
- Ondansetron hydrochloride
Other Indications
No indications returned.
Additional Documents
Committee Recommendations
The Surrey Heartlands APC approved doxylamine with pyridoxine for use in nausea and vomiting in pregnancy, acknowledging that the drug is licensed for this indication.
However, it was agreed that it should only be considered after a trial of a more established drug (off-label cyclizine, promethazine, prochlorperazine or chlorpromazine).
The Surrey Heartlands APC agreed a traffic light status and place in therapy for drugs used to treat nausea and vomiting in pregnancy.
Visit the Guideline Profile page for a full list of these drugs and to access the CKS guidelines for nasea & vomiting and pregnancy and the BUMPS website (Best Use of Medicines in Pregnancy).